“Phase II Trial of Romidepsin (FK228 or Depsipeptide) in Peripheral T-Cell Lymphoma: Clinical Activity and Molecular Markers”. Hematology Meeting Reports 2, no. 13 (June 10, 2009). Accessed April 19, 2026. https://journals.pagepress.net/hmr/article/view/482.